Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Uri Rozovski, Inbal Hazan-Halevy, Merav Barzilai, Michael J. Keating & Zeev Estrov. (2016) Metabolism pathways in chronic lymphocytic leukemia. Leukemia & Lymphoma 57:4, pages 758-765.
Read now
Read now
Articles from other publishers (36)
Roohi Mohi-ud-din, Apporva Chawla, Pooja Sharma, Prince Ahad Mir, Faheem Hyder Potoo, Željko Reiner, Ivan Reiner, Dilek Arslan Ateşşahin, Javad Sharifi-Rad, Reyaz Hassan Mir & Daniela Calina. (2023) Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects. European Journal of Medical Research 28:1.
Crossref
Crossref
Jianbo Wu, Fuqing Meng, Danyang Ran, Yalong Song, Yunkun Dang, Fan Lai, Longyan Yang, Mi Deng, Yuqin Song & Jun Zhu. (2023) The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma. Metabolites 13:6, pages 734.
Crossref
Crossref
Yu-Chan Chang, Ming-Hsien Chan, Yi-Fang Yang, Chien-Hsiu Li & Michael Hsiao. (2023) Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression. Cancer Letters 563, pages 216179.
Crossref
Crossref
Unnikrishnan Paruthiyezhath Shaji, Nikhil Tuti, Susmita Das, Roy Anindya & Monisha Mohan. (2022) Interactions between HIV protease inhibitor ritonavir and human DNA repair enzyme ALKBH2: a molecular dynamics simulation study. Molecular Diversity 27:2, pages 931-938.
Crossref
Crossref
Abdullah Alfaifi, Mohammed Y. Refai, Mohammed Alsaadi, Salem Bahashwan, Hafiz Malhan, Waiel Al-Kahiry, Enas Dammag, Ageel Ageel, Amjed Mahzary, Raed Albiheyri, Hussein Almehdar & Ishtiaq Qadri. (2023) Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin’s Lymphoma. Diagnostics 13:5, pages 861.
Crossref
Crossref
Yi Zhang, Fang Zhou, Jiaheng Guan, Lukun Zhou & Baoan Chen. (2023) Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review. Biomolecules 13:2, pages 250.
Crossref
Crossref
Mariana Tannoury, Delphine Garnier, Santos A. Susin & Brigitte Bauvois. (2022) Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?. Cancers 14:24, pages 6026.
Crossref
Crossref
Yu Nie, Xiaoya Yun, Ya Zhang & Xin Wang. (2022) Targeting metabolic reprogramming in chronic lymphocytic leukemia. Experimental Hematology & Oncology 11:1.
Crossref
Crossref
Yuan Huang, Longjun Xian, Zhongjian Liu, Ling Wei, Lu Qin, Yimei Xiong, Lei Hu, Siqi Zhou, Qiang Fu, Bo Li & Yang Qin. (2022) AMPKα2/HNF4A/BORIS/GLUT4 pathway promotes hepatocellular carcinoma cell invasion and metastasis in low glucose microenviroment. Biochemical Pharmacology 203, pages 115198.
Crossref
Crossref
Fengli Zuo, Jing Yu & Xiujing He. (2022) Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies. Frontiers in Oncology 12.
Crossref
Crossref
Jin-Song Yan, Meng-Ying Yang, Xue-Hong Zhang, Chen-Hui Luo, Cheng-Kan Du, Yue Jiang, Xuan-Jia Dong, Zhang-Man Wang, Li-Xue Yang, Yi-Dong Li, Li Xia & Ying Lu. (2022) Mitochondrial oxidative phosphorylation is dispensable for survival of CD34+ chronic myeloid leukemia stem and progenitor cells. Cell Death & Disease 13:4.
Crossref
Crossref
Manfei Pi, Huixian Kuang, Chunyan Yue, Qixuan Yang, Anqin Wu, Yuhua Li, Yehuda G. Assaraf, Dong-Hua Yang & Shaojie Wu. (2022) Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma. Drug Resistance Updates 61, pages 100822.
Crossref
Crossref
Makhloufi Zoulikha & Wei He. (2022) Targeted Drug Delivery for Chronic Lymphocytic Leukemia. Pharmaceutical Research 39:3, pages 441-461.
Crossref
Crossref
Lauren A. Thurgood, Oliver G. Best, Ashley Rowland, Karen M. Lower, Doug A. Brooks & Bryone J. Kuss. (2022) Lipid uptake in chronic lymphocytic leukemia. Experimental Hematology 106, pages 58-67.
Crossref
Crossref
Mojdeh Soltani, Yue Zhao, Zhijia Xia, Mazdak Ganjalikhani Hakemi & Alexandr V. Bazhin. (2021) The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies. Frontiers in Oncology 11.
Crossref
Crossref
Franziska von Heydebrand, Maximilian Fuchs, Meik Kunz, Simon Voelkl, Anita N. Kremer, Robert A. J. Oostendorp, Jochen Wilke, Michael Leitges, Alexander Egle, Andreas Mackensen & Gloria Lutzny-Geier. (2021) Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia. Stem Cells 39:6, pages 819-830.
Crossref
Crossref
Monika Podhorecka. (2021) Metformin - its anti-cancer effects in hematologic malignancies. Oncology Reviews 15:1.
Crossref
Crossref
Ademar Dantas da Cunha Júnior, Dalila Luciola Zanette, Fernando Vieira Pericole, Sara Teresinha Olalla Saad & José Barreto Campello Carvalheira. (2021) Obesity as a Possible Risk Factor for Progression from Monoclonal Gammopathy of Undetermined Significance Progression into Multiple Myeloma: Could Myeloma Be Prevented with Metformin Treatment?. Advances in Hematology 2021, pages 1-7.
Crossref
Crossref
Amina Mohammadalipour, Sandeep P. Dumbali & Pamela L. Wenzel. (2020) Mitochondrial Transfer and Regulators of Mesenchymal Stromal Cell Function and Therapeutic Efficacy. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Silvia Ravera, Fabio Ghiotto, Claudya Tenca, Elena Gugiatti, Sara Santamaria, Bernardetta Ledda, Adalberto Ibatici, Giovanna Cutrona, Andrea N. Mazzarello, Davide Bagnara, Martina Cardillo, Daniela Zarcone, Zbigniew Darzynkiewicz, Ermanno Ciccone, Franco Fais & Silvia Bruno. (2020) Berberine affects mitochondrial activity and cell growth of leukemic cells from chronic lymphocytic leukemia patients. Scientific Reports 10:1.
Crossref
Crossref
Nitya Nathwani, Joycelynne Palmer, Timothy W. Synold, Behrouz Salehian, Michael Rosenzweig, James F. Sanchez, Samantha N. Hammond, Kehinde Adekola, Valeria Tomarchio, Arnab Chowdhury, Chatchada Karanes, Myo Htut, Firoozeh Sahebi, Tanya Siddiqi, Amrita Krishnan, Stephen J. Forman & Steven T. Rosen. (2020) Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 20:10, pages e667-e672.
Crossref
Crossref
Sibi Raj, Vaishali Chandel & Dhruv Kumar. 2020. Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Cancer Cell Metabolism: A Potential Target for Cancer Therapy
1
13
.
Anna C. Beielstein & Christian P. Pallasch. (2019) Tumor Metabolism as a Regulator of Tumor–Host Interactions in the B-Cell Lymphoma Microenvironment—Fueling Progression and Novel Brakes for Therapy. International Journal of Molecular Sciences 20:17, pages 4158.
Crossref
Crossref
Gabriela Galicia-Vázquez & Raquel Aloyz. (2019) Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: How much do we actually know?. Critical Reviews in Oncology/Hematology 134, pages 65-70.
Crossref
Crossref
Gabriela Galicia-Vázquez & Raquel Aloyz. (2018) Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes. Frontiers in Oncology 8.
Crossref
Crossref
Corinna Seliger & Peter Hau. (2018) Drug Repurposing of Metabolic Agents in Malignant Glioma. International Journal of Molecular Sciences 19:9, pages 2768.
Crossref
Crossref
Giulia Biondani & Jean-François Peyron. (2018) Metformin, an Anti-diabetic Drug to Target Leukemia. Frontiers in Endocrinology 9.
Crossref
Crossref
Ademar Dantas Cunha Júnior, Fernando Vieira Pericole & Jose Barreto Campello Carvalheira. (2018) Metformin and blood cancers. Clinics 73, pages e412s.
Crossref
Crossref
Henrika Jodeleit, Omar Al-amodi, Janina Caesar, Christina Villarroel Aguilera, Lesca Holdt, Roswitha Gropp, Florian Beigel & Matthias Siebeck. (2018) Targeting ulcerative colitis by suppressing glucose uptake with ritonavir. Disease Models & Mechanisms.
Crossref
Crossref
Julia Starkova, Ivana Hermanova, Katerina Hlozkova, Alzbeta Hararova & Jan Trka. 2018.
93
147
.
Linda Sleire, Hilde Elise Førde, Inger Anne Netland, Lina Leiss, Bente Sandvei Skeie & Per Øyvind Enger. (2017) Drug repurposing in cancer. Pharmacological Research 124, pages 74-91.
Crossref
Crossref
Changyong Wei, Richa Bajpai, Horrick Sharma, Monique Heitmeier, Atul D. Jain, Shannon M. Matulis, Ajay K. Nooka, Rama K. Mishra, Paul W. Hruz, Gary E. Schiltz & Mala Shanmugam. (2017) Development of GLUT4-selective antagonists for multiple myeloma therapy. European Journal of Medicinal Chemistry 139, pages 573-586.
Crossref
Crossref
Xue Liang, Peiyan Kong, Jin Wang, Yulin Xu, Chunfang Gao & Guozhen Guo. (2017) Effects of metformin on proliferation and apoptosis of human megakaryoblastic Dami and MEG-01 cells. Journal of Pharmacological Sciences 135:1, pages 14-21.
Crossref
Crossref
Luqing Zhao, Yitao Mao, Yuelong Zhao, Ya Cao & Xiang Chen. (2016) Role of multifaceted regulators in cancer glucose metabolism and their clinical significance. Oncotarget 7:21, pages 31572-31585.
Crossref
Crossref
Panagiota Papanagnou, Theodora Stivarou & Maria Tsironi. (2016) Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs. Pharmaceuticals 9:2, pages 24.
Crossref
Crossref
Rama K. Mishra, Changyong Wei, Richard C. Hresko, Richa Bajpai, Monique Heitmeier, Shannon M. Matulis, Ajay K. Nooka, Steven T. Rosen, Paul W. Hruz, Gary E. Schiltz & Mala Shanmugam. (2015) In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy. Journal of Biological Chemistry 290:23, pages 14441-14453.
Crossref
Crossref